Back to search

Article

Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18 labelled tetrazine

2025-06-03

Abstract excerpt

<title>Abstract</title> <p>Antibody-based positron emission tomography (PET) imaging holds promise for visualising and quantifying disease-related proteins in the brain, yet clinical application has been limited by the poor blood-brain barrier (BBB) penetration of antibodies and the need for long-lived radionuclides. Pretargeted imaging offers a solution by separating the delivery of the antibody from the radiola...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1d04ab47-a9c3-5dad-8589-6c1988bb186a
DOI
10.21203/rs.3.rs-6784648/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18 labelled tetrazineDOI 10.21203/rs.3.rs-6784648/v1
Select a neighboring publication to make it the new centre.